Companies in the digital biomarkers sector developing innovative solutions and technologies.
Explore 1 recently funded digital biomarkers companies with verified founder contact information and fundraising data.
Cephalgo, based in Strasbourg, France, measures disease progression from speech for CNS clinical trials. Speech readings shift when phones or their software change mid-trial; Cephalgo keeps them stable by recalibrating from the audio. It also reviews recorded rater interviews (Trial QC).
The digital biomarkers sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Digital biomarkers companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The digital biomarkers sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 1 digital biomarkers companies tracked in the VCBacked database.
Companies in the digital biomarkers sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting digital biomarkers companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked